Skip to content
Home/Companies/Biotech/Lipocalyx

Lipocalyx

Biotech·Germany·Exited 2020·Held 9yr
Entry
2011
Hold
9yr
Exit
2020

Who owns Lipocalyx?

Lipocalyx was owned by High-Tech Gruenderfonds (HTGF) through HTGF II (2011 vintage) from 2011 to 2020, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-11

High-Tech Gruenderfonds (HTGF)
Investor
High-Tech Gruenderfonds (HTGF)
HTGF II · 2011 · VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2020

More from HTGF II

Other portfolio companies in the same fund.

Adlatus Robotics
Adlatus Robotics
Active
IndustrialsGermany· 2016
Adtriba
Active
AdTechGermany· 2016
casavi
casavi
Active
PropTechGermany· 2016
Cognigy
Cognigy
Exited 2025
AI/MLGermany· 2016
to
CommSolid
Exited 2018
Deep TechGermany· 2016
to
Cycle
Cycle
Active
SaaSGermany· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Lipocalyx

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Lipocalyx.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue